Narcotic antagonists in the therapy of shock
Patent 4267182 Issued on May 12, 1981. Estimated Expiration Date: 
January 16, 1999. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
January 16, 1999. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 2364833 2891954 3148118 3214341 3254088 3717643 3823234 1-Ethyl 3a-(substituted-phenyl) decahydroisoquinoline Process for promoting analgesia Endogenous morphine-like compound Patent #: 4042682 InventorsAssigneeApplicationNo. 06/003699 filed on 01/16/1979US Classes:514/282, One of the five cyclos is five-membered and includes ring chalcogen (e.g., codeine, morphine, etc.)514/295Two of the cyclos share at least three ring carbons (i.e., bridged) (e.g., benzomorphans, etc.)ExaminersPrimary: Ore, Dale R.Attorney, Agent or FirmInternational ClassesA61K 31/445 (20060101)A61K 31/485 (20060101) AbstractThe use of narcotic antagonists (e.g., naloxone) in shock therapy is disced.Other References
| |
